Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE

Sponsor
Wake Forest University (Other)
Overall Status
Terminated
CT.gov ID
NCT01005459
Collaborator
(none)
46
1
2
28.4
1.6

Study Details

Study Description

Brief Summary

The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when analgesia is requested will be randomized to receive a combined spinal-epidural containing either tetracaine 2 mg with fentanyl and epinephrine or bupivacaine 2 mg with fentanyl and epinephrine.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of Spinal Tetracaine With Fentanyl and Epinephrine Versus Bupivacaine With Fentanyl and Epinephrine for Combined Spinal Epidural Labor Analgesia
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Dec 12, 2011
Actual Study Completion Date :
Dec 12, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: tetracaine 2mg

Drug: Tetracaine
Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain.

Active Comparator: Bupivacaine 2 mg

Drug: Bupivacaine
Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain.

Outcome Measures

Primary Outcome Measures

  1. Spinal Analgesic Duration [1-2 hrs]

    duration of time in minutes from the time the combined spinal epidural is placed until the participant requests additional analgesia; at that time the epidural was dosed and study participation was complete

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • early labor (>=2cm but =<6cm cervical dilation)

  • at least 12 years of age

  • have an assigned ASA physical status 1 or 2

  • singleton pregnancy

Exclusion Criteria:
  • contraindications to neuraxial anesthesia

  • with allergies to drugs used in the study

  • have an assigned ASA status 3 or 4

  • advanced labor (> 6cm cervical dilation)

  • less than 12 years of age

  • Patients with the potential for distorted epidural anatomy, such as Harrington rods or prior back surgery, will also be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Forsyth Medical Center- OB Anesthesia dept Winston-Salem North Carolina United States 27103

Sponsors and Collaborators

  • Wake Forest University

Investigators

  • Principal Investigator: Peter H. Pan, MD, WFUHS

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wake Forest University
ClinicalTrials.gov Identifier:
NCT01005459
Other Study ID Numbers:
  • IRB 9824
First Posted:
Nov 1, 2009
Last Update Posted:
Nov 8, 2017
Last Verified:
Jun 1, 2017
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wake Forest University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Participants were approached after admission to the labor and delivery unit of our hospital about participation in this study
Pre-assignment Detail
Arm/Group Title Tetracaine 2mg Bupivacaine 2 mg
Arm/Group Description Tetracaine: Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain. Bupivacaine: Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain.
Period Title: Overall Study
STARTED 23 23
COMPLETED 23 23
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Tetracaine 2mg Bupivacaine 2 mg Total
Arm/Group Description Tetracaine: Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain. Bupivacaine: Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain. Total of all reporting groups
Overall Participants 23 23 46
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
23
100%
23
100%
46
100%
>=65 years
0
0%
0
0%
0
0%
Sex: Female, Male (Count of Participants)
Female
23
100%
23
100%
46
100%
Male
0
0%
0
0%
0
0%
Race/Ethnicity, Customized (Count of Participants)
white
18
78.3%
17
73.9%
35
76.1%
african american
5
21.7%
2
8.7%
7
15.2%
hispanic
0
0%
3
13%
3
6.5%
other
0
0%
1
4.3%
1
2.2%
Region of Enrollment (participants) [Number]
United States
23
100%
23
100%
46
100%

Outcome Measures

1. Primary Outcome
Title Spinal Analgesic Duration
Description duration of time in minutes from the time the combined spinal epidural is placed until the participant requests additional analgesia; at that time the epidural was dosed and study participation was complete
Time Frame 1-2 hrs

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Tetracaine 2mg Bupivacaine 2 mg
Arm/Group Description Tetracaine: Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain. Bupivacaine: Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain.
Measure Participants 23 23
Mean (Standard Deviation) [minutes]
92.68
(46.71)
89.61
(27.39)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Tetracaine 2mg
Comments
Type of Statistical Test Other
Comments unpaired t-test
Statistical Test of Hypothesis p-Value >0.05
Comments
Method unpaired t-test compared between groups
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Bupivacaine 2 mg
Comments
Type of Statistical Test Other
Comments unpaired t-test compared between groups
Statistical Test of Hypothesis p-Value >0.05
Comments
Method unpaired t-test compared between groups
Comments

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Tetracaine 2mg Bupivacaine 2 mg
Arm/Group Description Tetracaine: Tetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain. Bupivacaine: Bupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain.
All Cause Mortality
Tetracaine 2mg Bupivacaine 2 mg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/23 (0%) 0/23 (0%)
Serious Adverse Events
Tetracaine 2mg Bupivacaine 2 mg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/23 (0%) 0/23 (0%)
Other (Not Including Serious) Adverse Events
Tetracaine 2mg Bupivacaine 2 mg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/23 (0%) 0/23 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Peter H. Pan MD, MSEE
Organization Wake Forest School of Medicine-Anesthesiology
Phone 336-718-8278
Email ppan@wakehealth.edu
Responsible Party:
Wake Forest University
ClinicalTrials.gov Identifier:
NCT01005459
Other Study ID Numbers:
  • IRB 9824
First Posted:
Nov 1, 2009
Last Update Posted:
Nov 8, 2017
Last Verified:
Jun 1, 2017